CRISPR Therapeutics AG (CRSP)
54.21
-2.68
(-4.71%)
USD |
NASDAQ |
Jan 15, 16:00
54.21
0.00 (0.00%)
After-Hours: 16:11
CRISPR Therapeutics Market Cap: 5.166B for Jan. 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 111.40B |
| Intellia Therapeutics, Inc. | 1.377B |
| Beam Therapeutics, Inc. | 3.253B |
| Novartis AG | 274.73B |
| BeOne Medicines Ltd. | 37.40B |
Market Cap Related Metrics
| PS Ratio | 123.65 |
| PEG Ratio | -0.0995 |
| Price to Book Value | 2.696 |
| Price | 54.21 |
| Earnings Yield | -10.29% |
| PEGY Ratio | -0.0995 |